Inflectra

Active Ingredient(s): Infliximab-dyyb
FDA Approved: * April 5, 2016
Pharm Company: * CELLTRION INC
Category: Immunosuppressive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Inflectra Overview

Infliximab, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease.[1] It is given by slow injection into a vein, typically at six- to eight-week intervals.[1] Common side effects include infections, acute infusion reactions, and abdominal pain.[...

Read more Inflectra Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Infliximab

Recent Inflectra Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Infliximab-dyyb
  • Injection: 100mg
  • Vial: 100mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Inflectra: (1 result)

Sorted by National Drug Code
  • 0069-0809 Inflectra 100 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc

Other drugs which contain Infliximab-dyyb or a similar ingredient: (4 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA